ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1820

Statewide Burden of Osteoarthritis in United States Between 1990-2019: A Systematic and Comparative Benchmarking Study

Dhruvkumar Gadhiya1, Utsav Patel2, Hiren Chhayani3, Krushi Shah3, Sneh Patel3, Victor Adedara4, Divya Patel3, Hardik Desai5 and Swetha Chittipolu6, 1St.Luke's University Health, Anderson Campus, Easton, PA, 2Tulane University, New Orleans, LA, 3G.M.E.R.S. Medical College, Gandhinagar, Gandhinagar, India, 4St George’s University SOM, True Blue Greneda, True Blue, Grenada, 5Gujarat Adani Institute of Medical Sciences, Bhuj, India., Bhuj, India, 6North Mississippi Medical Center, Tupelo, MS

Meeting: ACR Convergence 2023

Keywords: Epidemiology, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1796–1826) Epidemiology & Public Health Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoarthritis (OA) is a prevalent and debilitating musculoskeletal condition that has imposed a significant burden on the United States (US) healthcare system. This study aims to explore the burden and trends of osteoarthritis in the US from 1990 to 2019.

Methods: Using the Global Burden of Disease methodology, this analysis presents a comprehensive overview of the Prevalence, Incidence, Disability adjusted life year (DALYs), Years lived with Disability (YLDs) by age, sex, year across the US from 1990-2019. All estimates were presented as total counts and age-standardized rates per 100 000 population, with uncertainty intervals (UIs).

Results: The prevalence cases of total osteoarthritis in the US nearly doubled from 28,873,208 (95%UIs: 25,939,261-32,228,468) in 1990 to 51,865,888 (46,804,271-57,860,984) in 2019. Similarly, the incidence of osteoarthritis increased from 1,990,039 (1,789,372-2,247,569) in 1990 to 3,462,236 (3,060,905-3,923,793) in 2019. The YLDs due to osteoarthritis also saw an upward trend, rising from 1,087,979 (556,601-2,194,304) in 1990 to 1,986,342 (1,023,960-3,964,292) in 2019. The annual percentage change (APC) in DALYs increased by 83% (75%-91%) from 1990 to 2019, indicating a substantial rise in the burden of osteoarthritis. The APC of age-standardized incidence rate (ASIR) increased by 6% (3%-10%), suggesting a steady growth in the occurrence of new cases. Among the states, Massachusetts experienced the highest incidence APC (13%), followed by California (12%) and Minnesota (10%) from 1990 to 2019. Interestingly, North Dakota was the only state that reported a decrease in the APC of ASIR by 2%. When analyzing the age-standardized DALYs rate (ASDALR), California exhibited the highest APC (12%), followed by Massachusetts (10%). Nevada had the highest APC in total incidence cases (226%), with Arizona closely behind at 158%. In contrast, the District of Columbia had the lowest APC in total incidence cases (23%) from 1990 to 2019. Regarding gender differences, females had a higher total number of incidence cases in the APC analysis (76% vs. 70%), while the increase in DALYs was similar for both males and females. Looking at specific age groups, Nevada and Alaska had the highest APC increase in incidence among individuals aged 95 and above, while North Dakota had the lowest APC in the 40-44 age group for females. For males, Nevada and Alaska had the highest APC increase in incidence among aged 95 and above, while Vermont had the lowest in the 40-44 age group.

Conclusion: In the US, the overall burden of osteoarthritis has steadily increased over the past three decades, with a notable variation in burden observed across different states. It is crucial to prioritize public health initiatives that promote healthy aging, early detection, and appropriate interventions. This includes raising awareness about the risk factors associated with osteoarthritis, implementing strategies to promote physical activity and healthy lifestyles, and ensuring equitable access to effective treatments and therapies.

Supporting image 1

Statewide distribution of Osteoarthritis in United States in 2019.

Supporting image 2

Burden of Osteoarthritis and its trend in United States between 1990_2019.

Supporting image 3

Age-wise distribution of Osteoarthritis in United States in 1990 and 2019.


Disclosures: D. Gadhiya: None; U. Patel: None; H. Chhayani: None; K. Shah: None; S. Patel: None; V. Adedara: None; D. Patel: None; H. Desai: None; S. Chittipolu: None.

To cite this abstract in AMA style:

Gadhiya D, Patel U, Chhayani H, Shah K, Patel S, Adedara V, Patel D, Desai H, Chittipolu S. Statewide Burden of Osteoarthritis in United States Between 1990-2019: A Systematic and Comparative Benchmarking Study [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/statewide-burden-of-osteoarthritis-in-united-states-between-1990-2019-a-systematic-and-comparative-benchmarking-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/statewide-burden-of-osteoarthritis-in-united-states-between-1990-2019-a-systematic-and-comparative-benchmarking-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology